Research graph
References from Intratumoral Microbiota in Fueling Cancer and Steering Treatment Response. Local targets link to admitted publications; unresolved targets remain external evidence.
Defining the Human Microbiome
10.1111/j.1753-4887.2012.00493.x · 2012 · External reference
Potential Effects of Gut Microbiota on Host Cancers: Focus on Immunity, DNA Damage, Cellular Pathways, and Anticancer Therapy
10.1038/s41396-023-01483-0 · 2023 · External reference
The Role of the Microbiome in Cancer Development and Therapy
2017 · External reference
CRC—All About Microbial Products and Barrier Function?
10.1038/nrgastro.2012.220 · 2012 · External reference
Gut Microbiota in Colorectal Cancer Development and Therapy
10.1038/s41571-023-00766-x · 2023 · External reference
Comprehensive Analysis of Microbial Content in Whole‐Genome Sequencing Samples From The Cancer Genome Atlas Project
10.1126/scitranslmed.ads6335 · 2025 · External reference
Role of Lung and Gut Microbiota on Lung Cancer Pathogenesis
10.1007/s00432-021-03644-0 · 2021 · External reference
Tumor‐Resident Intracellular Microbiota Promotes Metastatic Colonization in Breast Cancer
10.1016/j.cell.2022.02.027 · 2022 · External reference
The Human Tumor Microbiome Is Composed of Tumor Type–Specific Intracellular Bacteria
10.1126/science.aay9189 · 2020 · External reference
Hallmarks of Cancer: The Next Generation
10.1016/j.cell.2011.02.013 · 2011 · External reference
A Pan‐Cancer Mycobiome Analysis Reveals Fungal Involvement in Gastrointestinal and Lung Tumors
10.1016/j.cell.2022.09.015 · 2022 · External reference
Pan‐Cancer Analyses Reveal Cancer‐Type‐Specific Fungal Ecologies and Bacteriome Interactions
10.1016/j.cell.2022.09.005 · 2022 · External reference
The Gut Microbiota and Its Biogeography
10.1038/s41579-023-00969-0 · 2024 · External reference
Microbiota in Tumors: From Understanding to Application
10.1002/advs.202200470 · 2022 · External reference
Burkitt Lymphoma
10.1038/s41572-022-00404-3 · 2022 · External reference
HPV Vaccination and the Risk of Invasive Cervical Cancer
10.1056/nejmoa1917338 · 2020 · External reference
Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV‐Related HCC
10.1016/j.jcmgh.2023.01.001 · 2023 · External reference
Current Knowledge About Gastric Microbiota With Special Emphasis on Helicobacter Pylori‐Related Gastric Conditions
10.3390/cimb46050299 · 2024 · External reference
Increased ONECUT2 Induced by Helicobacter Pylori Promotes Gastric Cancer Cell Stemness via an AKT‐Related Pathway
10.1038/s41419-024-06885-2 · 2024 · External reference
A Review of Human Carcinogens—Part B: Biological Agents
10.1016/s1470-2045(09)70096-8 · 2009 · External reference
Intratumoral Microbiota: Roles in Cancer Initiation, Development and Therapeutic Efficacy
10.1038/s41392-022-01304-4 · 2023 · External reference
The Fungal Mycobiome Promotes Pancreatic Oncogenesis via Activation of MBL
10.1038/s41586-019-1608-2 · 2019 · External reference
Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
10.1016/j.ijrobp.2023.06.2515 · 2023 · External reference
Identification of Bacteria‐Derived HLA‐Bound Peptides in Melanoma
10.1038/s41586-021-03368-8 · 2021 · External reference
The Microbial Metabolite Trimethylamine N‐Oxide Promotes Antitumor Immunity in Triple‐Negative Breast Cancer
10.1016/j.cmet.2022.02.010 · 2022 · External reference
Sequencing Technologies — The Next Generation
10.1038/nrg2626 · 2010 · External reference
Best Practices for Analysing Microbiomes
10.1038/s41579-018-0029-9 · 2018 · External reference
Sequence‐Based Characterization of Intratumoral Bacteria—A Guide to Best Practice
10.3389/fonc.2020.00179 · 2020 · External reference
The Cancer Microbiome Atlas: A Pan‐Cancer Comparative Analysis to Distinguish Tissue‐Resident Microbiota From Contaminants
10.1016/j.chom.2020.12.001 · 2021 · External reference
Guidelines for Preventing and Reporting Contamination in Low‐Biomass Microbiome Studies
10.1038/s41564-025-02035-2 · 2025 · External reference
A Method for Selectively Enriching Microbial DNA From Contaminating Vertebrate Host DNA
10.1371/journal.pone.0076096 · 2013 · External reference
The Impact of Different Methods of DNA Extraction on Microbial Community Measures of BALF Samples Based on Metagenomic Data
2016 · External reference
Improving Saliva Shotgun Metagenomics by Chemical Host DNA Depletion
10.1186/s40168-018-0426-3 · 2018 · External reference
Microbial‐Enrichment Method Enables High‐Throughput Metagenomic Characterization From Host‐Rich Samples
10.1038/s41592-023-02025-4 · 2023 · External reference
Bayesian Community‐Wide Culture‐Independent Microbial Source Tracking
10.1038/nmeth.1650 · 2011 · External reference
Simple Statistical Identification and Removal of Contaminant Sequences in Marker‐Gene and Metagenomics Data
10.1186/s40168-018-0605-2 · 2018 · External reference
Exploration of Microbial Diversity Based on 16S rRNA Gene Sequence Analysis
2021 · External reference
Characterization of Human Breast Tissue Microbiota From Core Needle Biopsies Through the Analysis of Multi Hypervariable 16S‐rRNA Gene Regions
10.1038/s41598-018-35329-z · 2018 · External reference
Evaluation of 16S rRNA Gene Sequencing for Species and Strain‐Level Microbiome Analysis
10.1038/s41467-019-13036-1 · 2019 · External reference
Taxonomic Resolution of Different 16S rRNA Variable Regions Varies Strongly Across Plant‐Associated Bacteria
10.1093/ismeco/ycae034 · 2024 · External reference
Sensitivity and Correlation of Hypervariable Regions in 16S rRNA Genes in Phylogenetic Analysis
10.1186/s12859-016-0992-y · 2016 · External reference
Development of an Analysis Pipeline Characterizing Multiple Hypervariable Regions of 16S rRNA Using Mock Samples
10.1371/journal.pone.0148047 · 2016 · External reference
Intratumoral Microbiota Changes With Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma
2023 · External reference
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
10.1158/2159-8290.cd-17-1134 · 2018 · External reference
Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance Against Lung Metastases
10.1016/j.celrep.2018.08.090 · 2018 · External reference
Dietary Tryptophan Metabolite Released by Intratumoral Lactobacillus Reuteri Facilitates Immune Checkpoint Inhibitor Treatment
10.1016/j.cell.2023.03.011 · 2023 · External reference
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
10.1016/j.cell.2019.07.008 · 2019 · External reference
Comparison of Microbial Diversity Determined With the Same Variable Tag Sequence Extracted From Two Different PCR Amplicons
10.1186/1471-2180-13-208 · 2013 · External reference
A Comprehensive Analysis of Breast Cancer Microbiota and Host Gene Expression
10.1371/journal.pone.0188873 · 2017 · External reference
Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer
10.1038/s41586-022-05435-0 · 2022 · External reference
Spatial Meta‐Transcriptomics Reveal Associations of Intratumor Bacteria Burden With Lung Cancer Cells Showing a Distinct Oncogenic Signature
10.1136/jitc-2022-004698 · 2022 · External reference
Computational Methods and Challenges in Analyzing Intratumoral Microbiome Data
10.1016/j.tim.2023.01.011 · 2023 · External reference
Integrating Bulk and Single‐Cell RNA Sequencing Data Reveals the Relationship Between Intratumor Microbiome Signature and Host Metabolic Heterogeneity in Breast Cancer
10.3389/fimmu.2023.1140995 · 2023 · External reference
Breast Cancer Colonization by Fusobacterium nucleatum Accelerates Tumor Growth and Metastatic Progression
10.1038/s41467-020-16967-2 · 2020 · External reference
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor‐Immune Microenvironment
10.1016/j.chom.2013.07.007 · 2013 · External reference
Fap2 Mediates Fusobacterium Nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor‐Expressed Gal‐GalNAc
10.1016/j.chom.2016.07.006 · 2016 · External reference
Fusobacterium Nucleatum Adhesin FadA Binds Vascular Endothelial Cadherin and Alters Endothelial Integrity
10.1111/j.1365-2958.2011.07905.x · 2011 · External reference
Immune Checkpoint Blockade Induces Gut Microbiota Translocation That Augments Extraintestinal Antitumor Immunity
10.1126/sciimmunol.abo2003 · 2023 · External reference
CCR7/dendritic Cell Axis Mediates Early Bacterial Dissemination in Orientia Tsutsugamushi‐Infected Mice
10.3389/fimmu.2022.1061031 · 2022 · External reference
Intratumor Microbiome Features Reveal Antitumor Potentials of Intrahepatic Cholangiocarcinoma
10.1080/19490976.2022.2156255 · 2023 · External reference
Tumor Microbiome Links Cellular Programs and Immunity in Pancreatic Cancer
10.1016/j.ccell.2022.09.009 · 2022 · External reference
Multimodal Immune Phenotyping Reveals Microbial‐T Cell Interactions That Shape Pancreatic Cancer
10.1016/j.xcrm.2024.101397 · 2024 · External reference
High‐Resolution Bacterial 16S rRNA Gene Profile Meta‐Analysis and Biofilm Status Reveal Common Colorectal Cancer Consortia
10.1038/s41522-017-0040-3 · 2017 · External reference
The Bacteroides Fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients
10.1093/cid/ciu787 · 2015 · External reference
Association Between Fusobacterium Nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer
10.1245/s10434-018-6681-5 · 2018 · External reference
Fusobacterium nucleatum Load in MSI Colorectal Cancer Subtypes
10.1007/s10147-022-02218-5 · 2022 · External reference
Parvimonas micra Promotes Colorectal Tumorigenesis and Is Associated With Prognosis of Colorectal Cancer Patients
10.1038/s41388-022-02395-7 · 2022 · External reference
Human Colon Cancer–Derived Clostridioides Difficile Strains Drive Colonic Tumorigenesis in Mice
10.1158/2159-8290.cd-21-1273 · 2022 · External reference
Intratumor Microbiome Analysis Identifies Positive Association Between Megasphaera and Survival of Chinese Patients With Pancreatic Ductal Adenocarcinomas
10.3389/fimmu.2022.785422 · 2022 · External reference
Clostridium Butyricum and Its Metabolite Butyrate Promote Ferroptosis Susceptibility in Pancreatic Ductal Adenocarcinoma
10.1007/s13402-023-00831-8 · 2023 · External reference
Tumor Microbiome Contributes to an Aggressive Phenotype in the Basal‐Like Subtype of Pancreatic Cancer
10.1038/s42003-021-02557-5 · 2021 · External reference
Impact of Intratumoral Microbiome on Tumor Immunity and Prognosis in Human Pancreatic Ductal Adenocarcinoma
10.1007/s00535-023-02069-5 · 2024 · External reference
Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine
10.1126/science.aah5043 · 2017 · External reference
Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in Situ Tissue Microbiomes for Promoting Malignancy
10.3389/fonc.2018.00318 · 2018 · External reference
A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β‐Catenin Axes
10.1158/2159-8290.cd-20-0537 · 2021 · External reference
Interaction Between the Microbiome and TP53 in Human Lung Cancer
10.1186/s13059-018-1501-6 · 2018 · External reference
Intratumor Microbiome‐Derived Butyrate Promotes Lung Cancer Metastasis
10.1016/j.xcrm.2024.101488 · 2024 · External reference
Intratumoral Escherichia Is Associated With Improved Survival to Single‐Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small‐Cell Lung Cancer
10.1200/jco.23.01488 · 2024 · External reference
Exploring the Impact of Non‐Small Cell Lung Cancer Tumor Microbiome on the Efficacy of Chemotherapy and Immune Checkpoint Inhibitors
10.53388/2024724005 · 2024 · External reference
Tumor‐Resident Lactobacillus Iners Confer Chemoradiation Resistance Through Lactate‐Induced Metabolic Rewiring
10.1016/j.ccell.2023.09.012 · 2023 · External reference
The Intratumor Mycobiome Promotes Lung Cancer Progression via Myeloid‐Derived Suppressor Cells
10.1016/j.ccell.2023.08.012 · 2023 · External reference
Intratumour Microbiome Associated With the Infiltration of Cytotoxic CD8+ T Cells and Patient Survival in Cutaneous Melanoma
10.1016/j.ejca.2021.03.053 · 2021 · External reference
Microbiome Typing in Uveal Melanoma Is Associated With Plaque Radiotherapy
10.1016/j.medmic.2023.100079 · 2023 · External reference
Intratumoural Microbiome Can Predict the Prognosis of Hepatocellular Carcinoma After Surgery
10.1002/ctm2.1331 · 2023 · External reference
Intratumoral Microbiome of Human Primary Liver Cancer
10.1002/hep4.1908 · 2022 · External reference
Characterization of the Esophageal Microbiota and Prediction of the Metabolic Pathways Involved in Esophageal Cancer
10.3389/fcimb.2020.00268 · 2020 · External reference
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma
10.1158/0008-5472.can-22-2593 · 2023 · External reference
Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated With Prognosis
10.1158/1078-0432.ccr-16-1786 · 2016 · External reference
Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma
10.1158/1078-0432.ccr-19-0318 · 2019 · External reference
Presence of Porphyromonas Gingivalis in Esophagus and Its Association With the Clinicopathological Characteristics and Survival in Patients With Esophageal Cancer
10.1186/s13027-016-0049-x · 2016 · External reference
Porphyromonas Gingivalis Predicts Local Recurrence After Endoscopic Submucosal Dissection of Early Esophageal Squamous Cell Carcinoma or Precancerous Lesion
10.1186/s12885-022-10469-8 · 2023 · External reference
The Differential Distribution of Bacteria Between Cancerous and Noncancerous Ovarian Tissues in Situ
10.1186/s13048-019-0603-4 · 2020 · External reference
The Ovarian Cancer Oncobiome
10.18632/oncotarget.16717 · 2017 · External reference
The Biodiversity Composition of Microbiome in Ovarian Carcinoma Patients
10.1038/s41598-018-38031-2 · 2019 · External reference
The Bladder Microbiome Is Associated With Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
10.3390/cancers13153649 · 2021 · External reference
Alterations of Thyroid Microbiota Across Different Thyroid Microhabitats in Patients With Thyroid Carcinoma
10.1186/s12967-021-03167-9 · 2021 · External reference
Tumor Microbiome Diversity Influences Papillary Thyroid Cancer Invasion
10.1038/s42003-022-03814-x · 2022 · External reference
Potential Role of the Intratumoral Microbiota in Prognosis of Head and Neck Cancer
10.3390/ijms242015456 · 2023 · External reference
Multi‐Omics Integration Reveals the Crucial Role of Fusobacterium in the Inflammatory Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
10.1128/spectrum.01068-22 · 2022 · External reference
Prognostic Value of Intratumoral Fusobacterium nucleatum and Association With Immune‐Related Gene Expression in Oral Squamous Cell Carcinoma Patients
10.1038/s41598-021-86816-9 · 2021 · External reference
Microbial Peptides Activate Tumour‐Infiltrating Lymphocytes in Glioblastoma
10.1038/s41586-023-06081-w · 2023 · External reference
Multi‐Omics Analysis Reveals the Interplay Between Intratumoral Bacteria and Glioma
2025 · External reference
Characterization of the Tumor Microbiome of Brain Metastases and Glioblastoma Reveals Tumor‐Type‐Specific and Location‐Specific Microbial Signatures
10.1038/s43018-025-01073-3 · 2025 · External reference
Lung Cancer Shapes Commensal Bacteria via Exosome‐Like Nanoparticles
10.1016/j.nantod.2022.101451 · 2022 · External reference
Oncogenic Collagen I Homotrimers From Cancer Cells Bind to α3β1 Integrin and Impact Tumor Microbiome and Immunity to Promote Pancreatic Cancer
10.1016/j.ccell.2022.06.011 · 2022 · External reference
The Microbiome(s) and Cancer: Know Thy Neighbor(s)
10.1002/path.5661 · 2021 · External reference
Bidirectional Mediation Effects Between Intratumoral Microbiome and Host DNA Methylation Changes Contribute to Stomach Adenocarcinoma
2023 · External reference
Alterations of Gastric Mucosal Microbiota Across Different Stomach Microhabitats in a Cohort of 276 Patients With Gastric Cancer
10.1016/j.ebiom.2018.12.034 · 2019 · External reference
The Characterization of Lung Microbiome in Lung Cancer Patients With Different Clinicopathology
2019 · External reference
A Pilot Study Using Metagenomic Sequencing of the Sputum Microbiome Suggests Potential Bacterial Biomarkers for Lung Cancer
10.1371/journal.pone.0177062 · 2017 · External reference
Lower Airway Bacterial Microbiome May Influence Recurrence After Resection of Early‐Stage Non–Small Cell Lung Cancer
10.1016/j.jtcvs.2020.01.104 · 2021 · External reference
Characterizing Human Lung Tissue Microbiota and Its Relationship to Epidemiological and Clinical Features
10.1186/s13059-016-1021-1 · 2016 · External reference
Non‐Small Cell Lung Cancer Microbiota Characterization: Prevalence of Enteric and Potentially Pathogenic Bacteria in Cancer Tissues
10.1371/journal.pone.0249832 · 2021 · External reference
The Composition of Lung Microbiome in Lung Cancer: A Systematic Review and Meta‐Analysis
10.1186/s12866-021-02375-z · 2021 · External reference
Intratumoral Microbiota‐Host Interactions Shape the Variability of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma in Recurrence and Metastasis
10.1128/spectrum.03738-22 · 2023 · External reference
Association Between Smoking History and Tumor Mutation Burden in Advanced Non–Small Cell Lung Cancer
10.1158/0008-5472.can-20-3991 · 2021 · External reference
The Microbiome in Lung Cancer Tissue and Recurrence‐Free Survival
10.1158/1055-9965.epi-18-0966 · 2019 · External reference
The Characteristics of Intratumoral Microbial Community Reflect the Development of Lung Adenocarcinoma
10.3389/fmicb.2024.1353940 · 2024 · External reference
Leveraging Circulating Microbiome Signatures to Predict Tumor Immune Microenvironment and Prognosis of Patients With Non‐Small Cell Lung Cancer
10.1186/s12967-023-04582-w · 2023 · External reference
Circulating Microbiome DNA as Biomarkers for Early Diagnosis and Recurrence of Lung Cancer
10.1016/j.xcrm.2024.101499 · 2024 · External reference
The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
10.1016/j.trecan.2019.12.007 · 2020 · External reference
Commensal Microbiota Promote Lung Cancer Development via Γδ T Cells
10.1016/j.cell.2018.12.040 · 2019 · External reference
Phenotype, Distribution, Generation, and Functional and Clinical Relevance of Th17 Cells in the Human Tumor Environments
10.1182/blood-2009-03-208249 · 2009 · External reference
T Helper 17 Cells Play a Critical Pathogenic Role in Lung Cancer
10.1073/pnas.1319051111 · 2014 · External reference
IL‐17A‐Producing T Cells Are Associated With the Progression of Lung Adenocarcinoma
10.3892/or.2016.4837 · 2016 · External reference
Increased IL‐17‐Producing Cells Correlate With Poor Survival and Lymphangiogenesis in NSCLC Patients
10.1016/j.lungcan.2009.11.013 · 2010 · External reference
CARD9 Prevents Lung Cancer Development by Suppressing the Expansion of Myeloid‐Derived Suppressor Cells and IDO Production
10.1002/ijc.32355 · 2019 · External reference
Upregulation of miR‐675‐5p Induced by lncRNA H19 Was Associated With Tumor Progression and Development by Targeting Tumor Suppressor p53 in Non–Small Cell Lung Cancer
10.1002/jcb.29182 · 2019 · External reference
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
10.1158/2159-8290.cd-21-0324 · 2021 · External reference
Human Microbiota and Breast Cancer—Is There any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
10.3389/fmicb.2021.584332 · 2021 · External reference
Prognostic Correlations With the Microbiome of Breast Cancer Subtypes
10.1038/s41419-021-04092-x · 2021 · External reference
The Microbiota of Breast Tissue and Its Association With Breast Cancer
10.1128/aem.01235-16 · 2016 · External reference
Microbial Dysbiosis Is Associated With Human Breast Cancer
10.1371/journal.pone.0083744 · 2014 · External reference
Oxidative Stress and Counteracting Mechanisms in Hormone Receptor Positive, Triple‐Negative and Basal‐Like Breast Carcinomas
10.1186/1471-2407-11-262 · 2011 · External reference
Mycothiol: Synthesis, Biosynthesis and Biological Functions of the Major Low Molecular Weight Thiol in Actinomycetes
10.1039/b616489g · 2008 · External reference
Inorganic Arsenic Promotes Luminal to Basal Transition and Metastasis of Breast Cancer
10.1096/fj.202001192r · 2020 · External reference
Matrix Metalloproteinase‐9 (MMP‐9) and Its Inhibitors in Cancer: A Minireview
10.1016/j.ejmech.2020.112260 · 2020 · External reference
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E‐Cadherin/β‐Catenin Signaling via Its FadA Adhesin
10.1016/j.chom.2013.07.012 · 2013 · External reference
Genomic and Transcriptomic Landscape of Triple‐Negative Breast Cancers: Subtypes and Treatment Strategies
10.1016/j.ccell.2019.02.001 · 2019 · External reference
Multi‐Kingdom Microbiota Analyses Identify Bacterial–Fungal Interactions and Biomarkers of Colorectal Cancer Across Cohorts
10.1038/s41564-021-01030-7 · 2022 · External reference
A Novel Faecal Lachnoclostridium Marker for the Non‐Invasive Diagnosis of Colorectal Adenoma and Cancer
10.1136/gutjnl-2019-318532 · 2020 · External reference
Profiling of Host Genetic Alterations and Intra‐Tumor Microbiomes in Colorectal Cancer
10.1016/j.csbj.2021.05.049 · 2021 · External reference
Microbial Community Heterogeneity Within Colorectal Neoplasia and Its Correlation With Colorectal Carcinogenesis
10.1053/j.gastro.2021.02.020 · 2021 · External reference
Potential Role of the Intratumoral Microbiota in Colorectal Cancer Immunotherapy
10.1016/j.intimp.2024.112537 · 2024 · External reference
The Human Commensal Bacteroides fragilis Binds Intestinal Mucin
10.1016/j.anaerobe.2011.05.017 · 2011 · External reference
The Bacteroides Fragilis Pathogenicity Island Is Contained in a Putative Novel Conjugative Transposon
10.1128/jb.186.18.6077-6092.2004 · 2004 · External reference
Bacteroides Fragilis Enterotoxin Cleaves the Zonula Adherens Protein, E‐Cadherin
10.1073/pnas.95.25.14979 · 1998 · External reference
Bacteroides fragilis Enterotoxin Induces c‐Myc Expression and Cellular Proliferation
10.1053/gast.2003.50047 · 2003 · External reference
Enterotoxigenic Bacteroides Fragilis Induces the Stemness in Colorectal Cancer via Upregulating Histone Demethylase JMJD2B
10.1080/19490976.2020.1788900 · 2020 · External reference
Bacteroides fragilis Toxin Coordinates a Pro‐Carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
10.1016/j.chom.2018.01.007 · 2018 · External reference
Bacteroides Fragilis Enterotoxin Induces Intestinal Epithelial Cell Secretion of Interleukin‐8 Through Mitogen‐Activated Protein Kinases and a Tyrosine Kinase‐Regulated Nuclear Factor‐κB Pathway
10.1128/iai.72.10.5832-5839.2004 · 2004 · External reference
A Human Colonic Commensal Promotes Colon Tumorigenesis via Activation of T Helper Type 17 T Cell Responses
10.1038/nm.2015 · 2009 · External reference
Human Intestinal Lumen and Mucosa‐Associated Microbiota in Patients With Colorectal Cancer
10.1371/journal.pone.0039743 · 2012 · External reference
Targeting Programmed Fusobacterium Nucleatum Fap2 for Colorectal Cancer Therapy
10.3390/cancers11101592 · 2019 · External reference
Fusobacterium Nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll‐Like Receptor 4 Signaling to Nuclear Factor−κB, and Up‐Regulating Expression of MicroRNA‐21
10.1053/j.gastro.2016.11.018 · 2017 · External reference
Fusobacterium Nucleatum Promotes Chemoresistance to 5‐Fluorouracil by Upregulation of BIRC3 Expression in Colorectal Cancer
10.1186/s13046-018-0985-y · 2019 · External reference
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
10.1016/j.cell.2017.07.008 · 2017 · External reference
Fusobacterium Nucleatum Promotes Inflammatory and Anti‐Apoptotic Responses in Colorectal Cancer Cells via ADP‐Heptose Release and ALPK1/TIFA Axis Activation
10.1080/19490976.2023.2295384 · 2024 · External reference
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors From Immune Cell Attack
10.1016/j.immuni.2015.01.010 · 2015 · External reference
Fusobacterium Nucleatum Host‐Cell Binding and Invasion Induces IL‐8 and CXCL1 Secretion That Drives Colorectal Cancer Cell Migration
10.1126/scisignal.aba9157 · 2020 · External reference
Fusobacterium Nucleatum Drives a Pro‐Inflammatory Intestinal Microenvironment Through Metabolite Receptor‐Dependent Modulation of IL‐17 Expression
10.1080/19490976.2021.1987780 · 2021 · External reference
Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer
10.1126/science.aal5240 · 2017 · External reference
C‐Type Lectin Receptors Dectin‐3 and Dectin‐2 Form a Heterodimeric Pattern‐Recognition Receptor for Host Defense Against Fungal Infection
10.1016/j.immuni.2013.05.017 · 2013 · External reference
Fungal‐Induced Glycolysis in Macrophages Promotes Colon Cancer by Enhancing Innate Lymphoid Cell Secretion of IL‐22
2021 · External reference
Candida albicans Synergizes With Fusobacterium nucleatum in Colorectal Cancer Progression via the Flo9‐RadD Interaction
10.1016/j.ccell.2026.02.001 · 2026 · External reference
Cancer Statistics, 2018
2018 · External reference
Identification of Unique Neoantigen Qualities in Long‐Term Survivors of Pancreatic Cancer
10.1038/nature24462 · 2017 · External reference
Association of Fusobacterium Species in Pancreatic Cancer Tissues With Molecular Features and Prognosis
10.18632/oncotarget.3109 · 2015 · External reference
Comparisons of Oral, Intestinal, and Pancreatic Bacterial Microbiomes in Patients With Pancreatic Cancer and Other Gastrointestinal Diseases
10.1080/20002297.2021.1887680 · 2021 · External reference
Microbiota in Pancreatic Health and Disease: The Next Frontier in Microbiome Research
10.1038/s41575-019-0242-7 · 2020 · External reference
Gut‐Derived Lipopolysaccharide Remodels Tumoral Microenvironment and Synergizes With PD‐L1 Checkpoint Blockade via TLR4/MyD88/AKT/NF‐κB Pathway in Pancreatic Cancer
10.1038/s41419-021-04293-4 · 2021 · External reference
Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
10.1158/0008-5472.can-19-2080 · 2020 · External reference
Fungal Mycobiome Drives IL‐33 Secretion and Type 2 Immunity in Pancreatic Cancer
10.1016/j.ccell.2022.01.003 · 2022 · External reference
The Role of the Complement System in Cancer
10.1172/jci90962 · 2017 · External reference
Fusobacterium Nucleatum Induces Proliferation and Migration in Pancreatic Cancer Cells Through Host Autocrine and Paracrine Signaling
10.1126/scisignal.abn4948 · 2022 · External reference
A Pan‐Cancer Analysis of the Microbiome in Metastatic Cancer
10.1016/j.cell.2024.03.021 · 2024 · External reference
Microbiota Modulate Tumoral Immune Surveillance in Lung Through a γδT17 Immune Cell‐Dependent Mechanism
10.1158/0008-5472.can-13-2462 · 2014 · External reference
Divergent Tumor Immunity Determined by Bacteria‐Cancer Cell Engagement
10.1016/j.cell.2025.12.044 · 2026 · External reference
F. nucleatum Facilitates Oral Squamous Cell Carcinoma Progression via GLUT1‐Driven Lactate Production
10.1016/j.ebiom.2023.104444 · 2023 · External reference
Microbiota‐Derived Butyrate Promotes a FOXO1‐Induced Stemness Program and Preserves CD8+T Cell Immunity Against Melanoma
10.1016/j.immuni.2025.10.004 · 2025 · External reference
[Sodium Butyrate and Sorafenib Synergistically Inhibit Hepatocellular Carcinoma Cells Possibly by Inducing Ferroptosis Through Inhibiting YAP]
2024 · External reference
Tumor‐Infiltrating Bacteria Disrupt Cancer Epithelial Cell Interactions and Induce Cell‐Cycle Arrest
10.1016/j.ccell.2025.09.010 · 2025 · External reference
Genomic Aberrations After Short‐Term Exposure to Colibactin‐Producing E. coli Transform Primary Colon Epithelial Cells
10.1038/s41467-021-21162-y · 2021 · External reference
Helicobacter pylori and Gastric Cancer: Mechanisms and New Perspectives
10.1186/s13045-024-01654-2 · 2025 · External reference
Periodontitis Pathogen Porphyromonas Gingivalis Promotes Pancreatic Tumorigenesis via Neutrophil Elastase From Tumor‐Associated Neutrophils
10.1080/19490976.2022.2073785 · 2022 · External reference
Invasive Salmonella Typhimurium Colonizes Gallbladder and Contributes to Gallbladder Carcinogenesis Through Activation of Host Epigenetic Modulator KDM6B
10.1016/j.canlet.2025.217621 · 2025 · External reference
The Tumor Microbiome as a Predictor of Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors
10.1158/2767-9764.crc-23-0170 · 2024 · External reference
NALIRIFOX Versus Nab‐Paclitaxel and Gemcitabine in Treatment‐Naive Patients With Metastatic Pancreatic Ductal Adenocarcinoma (NAPOLI 3): A Randomised, Open‐Label, Phase 3 Trial
10.1016/s0140-6736(23)01366-1 · 2023 · External reference
The Tumour Microenvironment in Pancreatic Cancer — Clinical Challenges and Opportunities
10.1038/s41571-020-0363-5 · 2020 · External reference
Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer
10.1200/jco.23.01895 · 2023 · External reference
Intratumoral Bacteria May Elicit Chemoresistance by Metabolizing Anticancer Agents
10.1080/23723556.2017.1405139 · 2018 · External reference
Commensal Bacteria and Fungi Differentially Regulate Tumor Responses to Radiation Therapy
10.1016/j.ccell.2021.07.002 · 2021 · External reference
Microbiota‐Derived 3‐IAA Influences Chemotherapy Efficacy in Pancreatic Cancer
10.1038/s41586-023-05728-y · 2023 · External reference
Fusobacterium nucleatum‐Mimicking Nanovehicles to Overcome Chemoresistance for Breast Cancer Treatment by Eliminating Tumor‐Colonizing Bacteria
10.1016/j.chempr.2024.01.030 · 2024 · External reference
Blocking Fusobacterium nucleatum‐Host Cell Interactions With Responsive Supramolecular GalNAc‐Derived Nanoplatform for Enhanced Chemotherapy in Colorectal Cancer
10.1016/j.nantod.2024.102288 · 2024 · External reference
Photodynamic Eradication of Intratumoral Microbiota With Bacteria‐Targeted Micelles Overcomes Gemcitabine Resistance of Pancreatic Cancer
10.1002/agt2.423 · 2024 · External reference
Gut Microbiome Modulates Response to Anti–PD‐1 Immunotherapy in Melanoma Patients
10.1126/science.aan4236 · 2018 · External reference
Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti–PD‐L1 Efficacy
10.1126/science.aac4255 · 2015 · External reference
Microbiota Triggers STING‐Type I IFN‐Dependent Monocyte Reprogramming of the Tumor Microenvironment
10.1016/j.cell.2021.09.019 · 2021 · External reference
The Commensal Microbiome Is Associated With Anti–PD‐1 Efficacy in Metastatic Melanoma Patients
10.1126/science.aao3290 · 2018 · External reference
Microbiome‐Derived Inosine Modulates Response to Checkpoint Inhibitor Immunotherapy
10.1126/science.abc3421 · 2020 · External reference
Intratumoral Accumulation of Gut Microbiota Facilitates CD47‐Based Immunotherapy via STING Signaling
10.1084/jem.20192282 · 2020 · External reference
Transforming Intratumor Bacteria Into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno‐Chemodynamic Therapy of Triple‐Negative Breast Cancer
10.1021/jacs.3c09472 · 2023 · External reference
Oncolytic Bacteria VNP20009 Expressing IFNβ Inhibits Melanoma Progression by Remodeling the Tumor Microenvironment
10.1016/j.isci.2024.109372 · 2024 · External reference
Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors
10.7150/jca.12491 · 2015 · External reference
Therapeutic Advantage of Genetically Engineered Salmonella Typhimurium Carrying Short Hairpin RNA Against Inhibin Alpha Subunit in Cancer Treatment
10.1093/annonc/mdy240 · 2018 · External reference
Enhancement of Ovarian Cancer Chemotherapy by Delivery of Multidrug‐Resistance Gene Small Interfering RNA Using Tumor Targeting S Almonella
10.1111/jog.12598 · 2015 · External reference
RETRACTED: Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor‐Bearing Mice
10.1177/1533034615581977 · 2016 · External reference
i≫Salmonella Typhimurium≪/i≫ Inhibits Tumor Growth in a Mouse Model of Colon Cancer
10.1538/expanim.16-0033 · 2016 · External reference
Enhanced Therapeutic Effect of an Antiangiogenesis Peptide on Lung Cancer in Vivo Combined With Salmonella VNP20009 Carrying a Sox2 shRNA Construct
10.1186/s13046-016-0381-4 · 2016 · External reference
Aptamer‐Assisted Tumor Localization of Bacteria for Enhanced Biotherapy
10.1038/s41467-021-26956-8 · 2021 · External reference
Macrophage‐Mediated Tumor‐Targeted Delivery of Engineered Salmonella Typhimurium VNP20009 in Anti‐PD1 Therapy Against Melanoma
10.1016/j.apsb.2022.05.006 · 2022 · External reference
Phase I Study of the Intravenous Administration of Attenuated Salmonella Typhimurium to Patients With Metastatic Melanoma
10.1200/jco.2002.20.1.142 · 2002 · External reference
IL‐18‐Producing Salmonella Inhibit Tumor Growth
10.1038/cgt.2008.48 · 2008 · External reference
Attenuated Salmonella Engineered to Produce Human Cytokine LIGHT Inhibit Tumor Growth
10.1073/pnas.0701959104 · 2007 · External reference
Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent
10.1038/mt.2013.183 · 2013 · External reference
Two‐Step Enhanced Cancer Immunotherapy With Engineered Salmonella Typhimurium Secreting Heterologous Flagellin
10.1126/scitranslmed.aak9537 · 2017 · External reference
RGD Peptide Cell‐Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella ‐Mediated Cancer Therapy
10.7150/thno.16135 · 2016 · External reference
Ectopic Expression of cGAS in Salmonella Typhimurium Enhances STING‐Mediated IFN‐β Response in Human Macrophages and Dendritic Cells
10.1136/jitc-2022-005839 · 2023 · External reference
Application of Genetically Engineered Salmonella Typhimurium for Interferon‐Gamma–Induced Therapy Against Melanoma
10.1016/j.ejca.2016.10.010 · 2017 · External reference
Metabolic Modulation of Tumours With Engineered Bacteria for Immunotherapy
10.1038/s41586-021-04003-2 · 2021 · External reference
Engineered Commensal Microbes for Diet‐Mediated Colorectal‐Cancer Chemoprevention
10.1038/s41551-017-0181-y · 2018 · External reference
Intestinal Probiotics E. coli Nissle 1917 as a Targeted Vehicle for Delivery of p53 and Tum‐5 to Solid Tumors for Cancer Therapy
10.1186/s13036-019-0189-9 · 2019 · External reference
Engineered Probiotics for Local Tumor Delivery of Checkpoint Blockade Nanobodies
10.1126/scitranslmed.aax0876 · 2020 · External reference
Programmable Bacteria Induce Durable Tumor Regression and Systemic Antitumor Immunity
10.1038/s41591-019-0498-z · 2019 · External reference
Probiotic‐Guided CAR‐T Cells for Solid Tumor Targeting
10.1126/science.add7034 · 2023 · External reference
Ultrasound‐Controllable Engineered Bacteria for Cancer Immunotherapy
10.1038/s41467-022-29065-2 · 2022 · External reference
Precise Thermal Regulation of Engineered Bacteria Secretion for Breast Cancer Treatment in Vivo
10.1021/acssynbio.1c00452 · 2022 · External reference
Spatiotemporally Controllable Distribution of Combination Therapeutics in Solid Tumors by Dually Modified Bacteria
10.1002/adma.202106669 · 2022 · External reference
A Programmable Encapsulation System Improves Delivery of Therapeutic Bacteria in Mice
10.1038/s41587-022-01244-y · 2022 · External reference
Immunotherapy With Engineered Bacteria by Targeting the STING Pathway for Anti‐Tumor Immunity
10.1038/s41467-020-16602-0 · 2020 · External reference
Modular‐Designed Engineered Bacteria for Precision Tumor Immunotherapy via Spatiotemporal Manipulation by Magnetic Field
10.1038/s41467-023-37225-1 · 2023 · External reference
Bacteria‐Driven Hypoxia Targeting Delivery of Chemotherapeutic Drug Proving Outcome of Breast Cancer
10.1186/s12951-022-01373-1 · 2022 · External reference
Pre‐Treatment With Bifidobacterium infantis and Its Specific Antibodies Enhance Targeted Radiosensitization in a Murine Model for Lung Cancer
10.1007/s00432-020-03434-0 · 2021 · External reference
Probiotics Functionalized With a Gallium‐Polyphenol Network Modulate the Intratumor Microbiota and Promote Anti‐Tumor Immune Responses in Pancreatic Cancer
10.1038/s41467-024-51534-z · 2024 · External reference
Tumour‐Targeting Bacteria Engineered to Fight Cancer
10.1038/s41568-018-0070-z · 2018 · External reference
Comparison of Anticancer Activities and Biosafety Between Salmonella Enterica Serovar Typhimurium ΔppGpp and VNP20009 in a Murine Cancer Model
10.3389/fmicb.2022.914575 · 2022 · External reference
Salmonella Typhimurium Suppresses Tumor Growth via the Pro‐Inflammatory Cytokine Interleukin‐1β
10.7150/thno.11432 · 2015 · External reference
Immune Response Induced by Salmonella Typhimurium Defective in ppGpp Synthesis
10.1016/j.vaccine.2005.11.031 · 2006 · External reference
Oral Delivery of DNA Vaccines Using Attenuated Salmonella Typhimurium as Carrier
10.1111/j.1574-695x.2000.tb01448.x · 2000 · External reference
Emerging Strategies for Engineering Escherichia coli Nissle 1917‐Based Therapeutics
10.1016/j.tips.2022.02.002 · 2022 · External reference
Therapy of Solid Tumors Using Probiotic Symbioflor‐2 ‐ Restraints and Potential
10.18632/oncotarget.8027 · 2016 · External reference
Bioengineering of Bacteria for Cancer Immunotherapy
10.1038/s41467-023-39224-8 · 2023 · External reference
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell‐Mediated Anti‐Tumor Immunity
10.1016/j.celrep.2018.11.047 · 2018 · External reference
Dietary Fiber and Probiotics Influence the Gut Microbiome and Melanoma Immunotherapy Response
10.1126/science.aaz7015 · 2021 · External reference
Bifidobacterium Alters the Gut Microbiota and Modulates the Functional Metabolism of T Regulatory Cells in the Context of Immune Checkpoint Blockade
10.1073/pnas.1921223117 · 2020 · External reference
